Dir./Sr. Dir Payer Marketing

The Director / Senior Director, Payer Marketing Lead, NXC-201 will own the US payer value story, pre-approval information exchange materials, payer research, reimbursement resources and training for the national key account management (KAM) team. Reporting to the VP, Marketing & Market Access, who is accountable for overall access strategy, this role will translate strategic priorities and clinical and economic evidence into practical payer marketing deliverables.
Initial success will be measured by developing the value story and pre-approval information exchange (PIE) deck to support payer evaluation ahead of formulary and coverage decisions. Longer term, this role will lead payer marketing execution through launch, evolve materials based on customer feedback and help build capabilities as business needs grow.
This role is fully focused on the US and will initially be a hands-on individual contributor managing agencies and cross-functional deliverables. Success requires meaningful CAR-T launch and PIE experience, strong judgment and the ability to execute with a high degree of autonomy.
What You Will Do Build the Value Story and Payer Marketing Plan Develop the US payer marketing plan and payer value proposition for NXC-201
Lead development of the PIE deck and supporting materials for appropriate pre-approval information exchange with payers and other qualified healthcare decision-makers
Translate clinical, patient burden and economic evidence into clear value messages tailored to payer needs
Partner with Medical Affairs and HEOR contributors to identify evidence needs and shape value evidence planning
Use payer research and competitive intelligence to anticipate coverage criteria, utilization management requirements and barriers to access
Equip Teams for Coverage and Reimbursement Discussions Develop payer and account-team materials, value presentations, objection-handling resources and training to support launch coverage objectives
Partner with the national KAM lead to translate account needs and coverage barriers into materials and training that support formulary and medical policy evaluation
Develop reimbursement resources and provider economic materials using strategy and substantive inputs owned by Site Activation & Patient Services, including CAR-T acquisition, treatment setting and payment considerations
Coordinate with Site Activation Strategy & Patient Services lead to align access communications with treatment center readiness and patient support needs
Partner with Medical, Legal and Regulatory colleagues to ensure materials and activities undergo appropriate review and comply with applicable requirements
Drive Payer Marketing Launch Readiness Own the payer marketing launch plan, deliverables, readiness criteria and performance measures
Equip the national KAM team with materials and evidence resources to support coverage execution; identify gaps requiring tailored content or additional evidence
Coordinate with Brand Marketing, Medical Affairs, Commercial Operations and other partners to align value communication and launch execution
Partner with the commercial strategy and launch excellence lead on cross-commercial dependencies, milestones and overall launch planning and consolidated budget coordination
Identify payer marketing readiness risks and surface access barriers to the VP, Marketing & Market Access and relevant functional owners
Manage Partners and Marketing Investment Manage agency and vendor relationships and coordinate cross-functional contributors; help develop a small payer marketing team as needs evolve
Partner with the Trade & Pricing lead to incorporate relevant pricing, distribution and reimbursement inputs into the value story and payer materials
Manage payer marketing agencies, vendors and functional budgets; contribute to consolidated commercial budget planning
Use coverage updates from the KAM team and payer feedback and the effectiveness of access materials to refine strategy and execution
Maintain a close working partnership with the Site Activation & Patient Services lead, who separately owns those capabilities
Qualifications Education and Experience Bachelor's degree required; advanced degree (MBA, PharmD or equivalent) preferred
7+ years of progressive experience within the biopharmaceutical industry, including relevant payer marketing or market access experience; level will reflect the scope and impact of relevant experience
Hematology/oncology experience and demonstrated knowledge of CAR-T coverage and reimbursement required
Meaningful hands-on CAR-T experience in US payer marketing, market access or related commercial roles required
Hands-on experience contributing to a US product launch and developing materials or programs supporting payer evaluation and coverage required
Hands-on experience developing pre-approval information exchange materials and supporting their use with payers required
Experience developing payer value propositions, economic messaging and account-team tools
Demonstrated success leading complex cross-functional initiatives and managing strategic external partners
Experience in emerging biotechnology or launch-stage organizations preferred
Capabilities Deep understanding of US commercial and government payer dynamics, medical benefit coverage and CAR-T reimbursement
Ability to translate clinical and health economic evidence into credible value communication for healthcare decision-makers
Strong understanding of pre-approval information exchange and appropriate collaboration with Medical, Legal and Regulatory colleagues
Ability to connect payer strategy with provider economics, trade and pricing considerations, and patient access
Demonstrated ability to translate strategy into execution in fast-paced, resource-constrained environments
Proven ability to influence cross-functional teams and lead through a high degree of autonomy
Excellent communication, relationship-building, analytical and problem-solving skills
High degree of ownership, initiative, accountability and intellectual curiosity
Distinctive Strengths Equally comfortable developing strategy and personally executing the work required to deliver results
Collaborative, low-ego leader who can work across functions to achieve shared goals
Thrives in ambiguity and enjoys building new capabilities from the ground up
Able to prioritize effectively, deliver through agencies and external partners, and develop the ability to lead a small team as the function grows
Motivated by the opportunity to help bring a potentially transformative therapy to patients with significant unmet need
Location and Travel US-based, remote
Ability to travel up to 25% as required
About Immix Biopharma Immix Biopharma is committed to harnessing the immune system through innovative cell therapies and other modalities to deliver widely accessible cures. Patients are waiting.
Our lead asset, NXC-201, is a differentiated BCMA-directed CAR-T therapy being developed for relapsed/refractory AL amyloidosis—an area of critical unmet need. We are advancing rapidly toward potential approval and launch, with the goal of bringing a transformative therapy to patients.
We are guided by three core values: Intelligence, Integrity, and Initiative . We are building a team of thoughtful, driven individuals who are motivated by the opportunity to make a meaningful impact for patients and to help define the future of our company.

#J-18808-Ljbffr